1. An overview on application of phage display technique in immunological studies
Abbas RAMI ; Mahdi BEHDANI ; Fatemeh KAZEMI-LOMEDASHT ; Najmeh YARDEHNAVI ; Najmeh YARDEHNAVI ; Mahdi HABIBI-ANBOUHI
Asian Pacific Journal of Tropical Biomedicine 2017;7(7):599-602
Phage display is very strong technique in drug discovery and development. Phage display has many applications in improving the immunological studies. Development of monoclonal antibody, peptides, peptidomimetics and epitope mapping are main application of phage display. Selection of monoclonal antibody or peptides that are displayed on the surface of the phages can be occurred through biopanning process. In biopanning process phage library is incubated with antigen and particular phages can be identified and isolated. Increasing the stringency in the biopanning rounds can be help to select phages with high affinity and specificity. Here, we describe an overview of phage display application with focusing on monoclonal antibody production and epitope mapping.
2. Recombinant expression and purification of functional vascular endothelial growth factor-121 in the baculovirus expression system
Nastaran MOHSENI ; Fatemeh KAZEMI-LOMEDASHT ; Delavar SHAHBAZZADEH ; Mahdi BEHDANI ; Ali JAHANIAN-NAJAFABADI ; Roghaye AREZOMAND ; Mahdi HABIBI-ANBOUHI
Asian Pacific Journal of Tropical Medicine 2016;9(12):1195-1199
Objective To express human vascular endothelial growth factor121 (VEGF121) in insect cells. Methods A gene construct containing VEGF was cloned in the pFastBac-HTA vector, followed by transformation in DH10BAC. The recombinant bacmid was then extracted, and transfected into Sf9 insect cells. The transfected cells were harvested, and then VEGF expression was confirmed by western blotting using specific antibodies. The tube formation assay was used for functional assessment of VEGF. Results Our results showed that VEGF could be successfully expressed in the baculovirus system. Purified VEGF was able to stimulate in vitro tube formation of human endothelial cells. Conclusions Results from this study demonstrated that the recombinantly-produced VEGF can be considered as a promising candidate for therapeutic purposes.